233.98MMarket Cap-847P/E (TTM)
1.290High1.190Low1.19MVolume1.250Open1.220Pre Close1.48MTurnover1.02%Turnover RatioLossP/E (Static)191.79MShares3.24052wk High-1.09P/B142.55MFloat Cap0.73252wk Low--Dividend TTM116.85MShs Float16.900Historical High--Div YieldTTM8.20%Amplitude0.732Historical Low1.247Avg Price1Lot Size
Scilex Holding Stock Forum
Scilex Holding Company Enters into Master Distributor Agreement Among CH Trading Group and Devart Middle East for the Distribution of ZTlido® in Morocco, Tunisia, Libya, Jordan, Iraq, and South Africa
Scilex Holding Company (Nasdaq: SCLX) has entered into a Master Distributor Agreement with Devart Middle East Food Supplements and CH Trading Group to expand the distribution of ZTlido® in Morocco, Tunisia, Libya, Jordan, Iraq, and South Africa. ZTlido® is a lidocaine ...
Scilex Holding Company Strengthens Board of Directors With Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.d.
Let's see how high is the highly accomplished one
Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in Far East Region
Scilex Holding Company (Nasdaq: SCLX) has entered a Memorandum of Understanding (MOU) with ACEA Therapeutics for collaboration on ZTlido®, a lidocaine topical system for neuropathic pain relief. The a...
Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
▪️The Phase 3 study results are being published in PAIN® Journal, which is the leading journal devoted to pain medicine and research. PAIN is the official journal of the Internation...
No comment yet